Boxer Capital as of Sept. 30, 2023
Portfolio Holdings for Boxer Capital
Boxer Capital holds 73 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirati Therapeutics | 7.4 | $140M | 3.2M | 43.56 | |
| Revolution Medicines (RVMD) | 6.9 | $130M | 4.7M | 27.68 | |
| BeiGene Sponsored ADR | 4.8 | $90M | 500k | 179.87 | |
| Tyra Biosciences (TYRA) | 4.7 | $89M | 6.4M | 13.77 | |
| Akero Therapeutics (AKRO) | 4.5 | $85M | 1.7M | 50.58 | |
| Tango Therapeutics (TNGX) | 4.3 | $80M | 7.1M | 11.26 | |
| Springworks Therapeutics (SWTX) | 4.2 | $79M | 3.4M | 23.12 | |
| Sarepta Therapeutics (SRPT) | 3.9 | $73M | 600k | 121.22 | |
| Apellis Pharmaceuticals (APLS) | 3.5 | $66M | 1.7M | 38.04 | |
| Cytokinetics Com New (CYTK) | 3.3 | $62M | 2.1M | 29.46 | |
| Ideaya Biosciences (IDYA) | 3.2 | $59M | 2.2M | 26.98 | |
| Nuvalent Inc-a (NUVL) | 3.0 | $56M | 1.2M | 45.97 | |
| ImmunoGen | 2.5 | $47M | 3.0M | 15.87 | |
| Merus N V (MRUS) | 2.4 | $45M | 1.9M | 23.58 | |
| Karuna Therapeutics Ord | 2.3 | $42M | 250k | 169.09 | |
| Argenx SE Sponsored ADR (ARGX) | 2.2 | $42M | 85k | 491.63 | |
| Legend Biotech Corp Sponsored ADS (LEGN) | 2.1 | $40M | 600k | 67.17 | |
| Amylyx Pharmaceuticals (AMLX) | 2.0 | $38M | 2.1M | 18.31 | |
| SPDR Ser Tr S&P Biotech (XBI) | 1.9 | $37M | 500k | 73.02 | |
| Prothena Corp SHS (PRTA) | 1.6 | $30M | 625k | 48.25 | |
| Rocket Pharmaceuticals (RCKT) | 1.6 | $30M | 1.5M | 20.49 | |
| Ventyx Biosciences (VTYX) | 1.6 | $30M | 850k | 34.73 | |
| Immunovant (IMVT) | 1.5 | $29M | 750k | 38.39 | |
| Arcus Biosciences Incorporated (RCUS) | 1.5 | $29M | 1.6M | 17.95 | |
| Amicus Therapeutics (FOLD) | 1.5 | $28M | 2.3M | 12.16 | |
| Axsome Therapeutics (AXSM) | 1.5 | $28M | 400k | 69.89 | |
| Exelixis (EXEL) | 1.3 | $25M | 1.2M | 21.85 | |
| Anaptysbio Inc Common (ANAB) | 1.2 | $23M | 1.3M | 17.96 | |
| Sage Therapeutics (SAGE) | 1.2 | $23M | 1.1M | 20.58 | |
| Viking Therapeutics (VKTX) | 1.2 | $22M | 2.0M | 11.07 | |
| Xenon Pharmaceuticals (XENE) | 1.1 | $21M | 600k | 34.16 | |
| Iteos Therapeutics (ITOS) | 1.1 | $20M | 1.8M | 10.95 | |
| Pmv Pharmaceuticals (PMVP) | 1.0 | $19M | 3.2M | 6.14 | |
| Iovance Biotherapeutics (IOVA) | 0.9 | $17M | 3.7M | 4.55 | |
| Point Biopharma Global | 0.9 | $17M | 2.5M | 6.67 | |
| Kalvista Pharmaceuticals (KALV) | 0.8 | $16M | 1.7M | 9.63 | |
| Relay Therapeutics (RLAY) | 0.8 | $15M | 1.8M | 8.41 | |
| Madrigal Pharmaceuticals (MDGL) | 0.8 | $15M | 100k | 146.04 | |
| Day One Biopharmaceuticals I (DAWN) | 0.8 | $15M | 1.2M | 12.27 | |
| Oric Pharmaceuticals (ORIC) | 0.6 | $11M | 1.7M | 6.05 | |
| Cullinan Oncology (CGEM) | 0.5 | $9.7M | 1.1M | 9.05 | |
| Nurix Therapeutics (NRIX) | 0.5 | $9.6M | 1.2M | 7.86 | |
| Acumen Pharmaceuticals (ABOS) | 0.5 | $9.2M | 2.2M | 4.15 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.5 | $9.0M | 450k | 20.06 | |
| Ascendis Pharma A/S Sponsored ADR (ASND) | 0.5 | $8.9M | 95k | 93.64 | |
| Enliven Therapeutics (ELVN) | 0.5 | $8.8M | 646k | 13.66 | |
| Prelude Therapeutics (PRLD) | 0.4 | $7.7M | 2.5M | 3.09 | |
| Avidity Biosciences Ord (RNA) | 0.4 | $7.2M | 1.1M | 6.38 | |
| Geron Corporation (GERN) | 0.3 | $6.4M | 3.0M | 2.12 | |
| Gossamer Bio (GOSS) | 0.3 | $5.4M | 6.5M | 0.83 | |
| Cogent Biosciences (COGT) | 0.3 | $5.1M | 525k | 9.75 | |
| Centessa Pharmaceuticals Sponsored ADS (CNTA) | 0.3 | $5.0M | 771k | 6.47 | |
| Rapt Therapeutics (RAPT) | 0.3 | $5.0M | 300k | 16.62 | |
| Third Harmonic Bio (THRD) | 0.2 | $3.3M | 520k | 6.39 | |
| Mersana Therapeutics (MRSN) | 0.1 | $2.5M | 2.0M | 1.27 | |
| Eqrx | 0.1 | $2.2M | 1.0M | 2.22 | |
| Health Sciences Acq Corp 2 (OBIO) | 0.1 | $2.1M | 238k | 8.72 | |
| 2Seventy Bio Common Stock (TSVT) | 0.1 | $1.8M | 460k | 3.92 | |
| Black Diamond Therapeutics (BDTX) | 0.1 | $1.5M | 506k | 2.87 | |
| DBV Technologies S A Sponsored ADR | 0.1 | $1.3M | 985k | 1.36 | |
| Bioatla (BCAB) | 0.1 | $1.2M | 686k | 1.70 | |
| Kodiak Sciences (KOD) | 0.1 | $1.1M | 600k | 1.80 | |
| Fate Therapeutics (FATE) | 0.1 | $1.1M | 500k | 2.12 | |
| Rain Therapeutics | 0.1 | $993k | 1.2M | 0.86 | |
| Milestone Pharmaceuticals (MIST) | 0.1 | $958k | 309k | 3.10 | |
| Verrica Pharmaceuticals (VRCA) | 0.0 | $649k | 167k | 3.88 | |
| Atreca CL A Com (BCEL) | 0.0 | $575k | 2.2M | 0.26 | |
| Ngm Biopharmaceuticals | 0.0 | $535k | 500k | 1.07 | |
| Theseus Pharmaceuticals | 0.0 | $404k | 150k | 2.69 | |
| Protara Therapeutics Com STK (TARA) | 0.0 | $349k | 209k | 1.67 | |
| ZIOPHARM Oncology | 0.0 | $145k | 1.1M | 0.13 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $27k | 267k | 0.10 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $2.7k | 67k | 0.04 |
